Product Description

🔹 Product Overview
Ibyra 150 mg Tablet is a prescription anticancer medicine used in the treatment of specific types of cancer associated with genetic mutations.
Contains Olaparib 150 mg, a targeted therapy that belongs to the class of PARP inhibitors.
Commonly prescribed for the management of ovarian cancer, breast cancer, pancreatic cancer, and prostate cancer in eligible patients.

🔹 Key Uses
Treatment of ovarian cancer
Management of breast cancer
Treatment of certain pancreatic cancers
Management of selected prostate cancers
Maintenance therapy in patients with specific genetic mutations such as BRCA-related cancers

🔹 Composition
Active ingredient: Olaparib 150 mg
Belongs to the PARP inhibitor class
Used in targeted cancer therapy

🔹 How It Works
Blocks the activity of the PARP enzyme involved in DNA repair
Prevents cancer cells from repairing damaged DNA
Promotes cancer cell death while helping slow tumor growth and progression

🔹 Key Benefits
Advanced targeted cancer treatment
Helps delay disease progression
Supports long-term cancer management in eligible patients
Convenient oral tablet formulation
Widely used in precision oncology treatment plans

🔹 Dosage and Administration
Take exactly as prescribed by an oncologist
Swallow tablets whole with water
Can be taken with or without food unless otherwise directed
Do not crush, chew, or split the tablets
Regular medical monitoring is required during treatment

🔹 Possible Side Effects
Nausea
Fatigue
Vomiting
Diarrhea
Loss of appetite
Anemia
Headache
Low blood cell counts

🔹 Precautions
Use only under specialist oncology supervision
Regular blood tests may be required
Inform your doctor about liver, kidney, or lung disorders
Avoid pregnancy during treatment
Inform your healthcare provider about all medications and supplements being used